Moreover, another tumor carried the intergenic fusion TBL1XR1(1)–PIK3CA(2) (T1), although orthogonal validation using RT-PCR and Sanger sequencing could not confirm its presence. This evidence concerns the gene TBL1XR1 and neoplasm.